Advertisement · 728 × 90
#
Hashtag
#TOMSCapital
Advertisement · 728 × 90
Toms Capital seeks CSX board meeting after taking stake - Reuters Investing.com -- Hedge fund Toms Capital Investment Management has requested a meeting with the board of U.S. railroad operator CSX (NASDAQ:CSX) after acquiring a stake in the company, potentially signaling a push for a merger, according to a report from Reuters. Toms Capital, led by Ben Pass, purchased 5.6 million shares of CSX common stock during the second quarter, according to a recent filing showing the position as of June 30. While the hedge fund’s specific intentions remain unclear, Pass has previously advocated for mergers at companies including U.S. Steel and Kenvue (NYSE:KVUE), the maker of Band-Aid and Tylenol products. The timing of Toms Capital’s investment coincides with growing speculation about potential railroad consolidation following last month’s deal between Union Pacific (NYSE:UNP) and Norfolk Southern (NYSE:NSC). This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Click Subscribe #TomsCapital #CSX #StockMarket #Investing #BoardMeeting

0 0 0 0
Preview
Exclusive-Toms Capital seeks CSX meeting after acquiring stake, sources say By Svea Herbst-Bayliss NEW YORK (Reuters) -Hedge fund Toms Capital Investment Management has requested to meet with the board at U.S. railroad operator CSX (NASDAQ:CSX) after recently buying a stake, people familiar with the matter said, raising speculation the firm may push for a possible merger. Toms Capital, run by Ben Pass, invested in the railroad during the second quarter, holding 5.6 million shares of common stock in CSX as of June 30, a new filing showed. It is unclear exactly what the firm wants but Pass has a history of pushing for mergers at companies like U.S. Steel and the Band-Aid and Tylenol maker, Kenvue (NYSE:KVUE). The hedge fund invested and is reaching out to the company at a time speculation is mounting that fresh railroad mergers are likely after Union Pacific (NYSE:UNP) and Norfolk Southern (NYSE:NSC) inked a deal last month. Unlike some activist investors, Toms Capital prefers to stay in the background and push for changes out of the limelight, rather than launching public and noisy campaigns. A representative for Toms Capital declined to comment. CSX did not immediately respond to a request for comment. CSX is no stranger to activist investors and previously worked with investor Mantle Ridge, whose founder Paul Hilal, now serves on the CSX board. Toms is not the only firm to have invested in the railroad during the second quarter. Ancora Holdings also established a toehold investment and has been considering more purchases, a person familiar with the firm’s trading patterns said. A spokesman for Ancora declined to comment. Ancora has a history of pushing for changes and won board seats last year at rival railroad Norfolk Southern. Investors have said CSX needs to find a partner of its own now, raising the possibility of potential talks with Berkshire Hathaway-owned BNSF Railway and others. Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks AI – 6 model portfolios fueled by AI stock picks with a stellar performance this year... In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if CSX is on your watchlist, it could be very wise to know whether or not it made the ProPicks AI lists.

Click Subscribe #TomsCapital #CSX #StockMarket #Investing #FinanceNews

0 0 0 0
TOMS Capital pushes for Kenvue sale, Bloomberg News reports © Reuters. (Reuters) -Investment firm TOMS Capital Investment Management has amassed a stake in the Band-Aid maker Kenvue (NYSE:KVUE) and is pushing the company to consider a full sale or separation of some assets, Bloomberg News reported on Sunday, citing people with knowledge of the matter. It was not immediately clear the extent of the hedge fund’s total stakeholding in Kenvue. Kenvue, previously a part of Johnson & Johnson (NYSE:JNJ), settled a four-month battle with activist investor Starboard Value earlier this month by appointing three new directors to its board as part of an agreement. Starboard Value built a stake in Kenvue in October, sparking criticism over the lackluster performance in the skin health and beauty segment, which houses brands such as Neutrogena and Aveeno. TOMS Capital declined to comment and Kenvue did not immediately respond to a Reuters request for comment, while a spokesperson for Kenvue told Bloomberg News, "Kenvue’s board and management team are committed to acting in the best interests of the company and all shareholders and we remain focused on accelerating sustainable, profitable growth and enhancing shareholder value." Which stock should you buy in your very next trade? AI computing powers are changing the stock market. Investing.com's ProPicks AI includes 6 winning stock portfolios chosen by our advanced AI. In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. Which stock will be the next to soar? Unlock ProPicks AI 0 Latest comments

Click Subscribe #TOMSCapital #Kenvue #InvestmentNews #StockMarket #ActivistInvestors

0 0 0 0